Terkko Navigator / -/ Feeds / " ( ( Eturauhanen )|( Prostata )|( Prostata )|( Glandula prostatica )|( Gl. prostatica )|( "

Can machine learning-based analysis of multiparameter MRI and clinical parameters improve the performance of clinically significant prostate cancer diagnosis?

Biomolecules, Vol. 11, Pages 1572: Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing

SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways

JPM, Vol. 11, Pages 1061: Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients

Conserved Structure Modules within the lncRNA SChLAP1 Mediate Protein Recognition Implicated in Aggressive Prostate Cancer

Dietary pterostilbene for MTA1-targeted interception in high-risk premalignant prostate cancer

Transrectal ultrasound-guided prostate needle biopsy remains a safe method in confirming a prostate cancer diagnosis: a multicentre Australian analysis of infection rates

Is the Success of Adaptive Therapy in Metastatic Castrate Resistant Prostate Cancer Influenced by Cell-Type-Dependent Production of Prostate Specific Antigen?

Viruses, Vol. 13, Pages 2085: Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV

Viruses, Vol. 13, Pages 2085: Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSV

Sensors, Vol. 21, Pages 6708: A Deep Learning Pipeline for Grade Groups Classification Using Digitized Prostate Biopsy Specimens

A call for HoLEP: AEEP for mega-prostates (≥ 200 cc)

Glucocorticoid signaling delays castration-induced regression in murine models of prostate cancer

Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy

Prostate cancer risk prediction using a polygenic risk score

Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.

Prostate specific antigen for early detection of prostate cancer: longitudinal study.

Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial.

Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial.

Prostate-cancer mortality at 11 years of follow-up.

Prostate-cancer mortality at 11 years of follow-up.

Prostate-cancer mortality at 11 years of follow-up.

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy for Prostate Cancer: Current Status and Perspectives.

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data